{"filings":[{"id":2087997,"accession_number":"0001193125-26-336643","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2026-08-06T10:53:21+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Genesco CSO Parag Desai to retire Oct 31, 2026; transition to part-time Aug 7","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Parag Desai transitions to part-time SVP, Chief Strategy and Digital Officer on Aug 7, 2026; retires Oct 31, 2026.","During transition, Desai receives $10,000/month for up to 32 hours; eligible for FY2027 STIP target bonus of $338,000.","Outstanding PSU awards (granted Apr 2024 and Jul 2025) receive retirement treatment; part-time status not a termination.","Post-retirement consulting from Nov 1, 2026 through Jan 31, 2027 at $2,400/day for up to 8 hours/day.","Responsibilities will transition to other senior leadership team members; Desai joined Genesco in 2014."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1804276,"accession_number":"0001193125-26-312503","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2026-07-22T20:52:37+00:00","items":["5.07"],"status":"ready","headline":"Genesco shareholders re-elect all nine board nominees; reject dissident slate from Bradley Radoff","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All nine company-nominated directors elected with ~8.4M votes each; dissident nominees Ballard and Poskon received ~1M votes.","Advisory vote on executive compensation passed with 8.2M For, 1.1M Against.","Fourth Amended and Restated 2020 Equity Incentive Plan approved with 5.1M For vs 4.3M Against (close vote).","Ratification of Deloitte as auditor for FY2027 approved with 8.4M For, 1.1M Against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.15,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1315038,"accession_number":"0001193125-26-286803","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2026-06-29T10:51:44+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Genesco names Jonathan Collins as CFO, effective August 3, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jonathan Collins appointed SVP, Finance and CFO; starts Aug 3, 2026.","Collins previously CFO of America's Car-Mart and senior finance roles at Walmart.","Total compensation: base $550K, target short-term 75%, long-term 150% of base.","Mimi Vaughn will cease serving as interim CFO upon Collins' effective date.","Collins receives $25K/quarter relocation stipend for three quarters."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":731196,"accession_number":"0001193125-26-246280","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2026-05-29T11:07:04+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco reports Q1 sales beat, raises FY2027 EPS outlook; launches $40-50M cost program","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales of $487M rose 3% YoY; comparable sales increased 2% with 3% same-store growth.","Journeys comparable sales +5%, Johnston & Murphy +7%; Schuh declined 9% due to promotion pullback.","GAAP operating loss improved to $15.4M from $28.1M; adjusted EPS loss of $2.18 per share.","Full-year adjusted EPS guidance raised to $2.00-$2.40 from prior $1.90-$2.30.","Company announces new cost reduction program targeting $40-$50M in savings by fiscal 2029."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96218,"accession_number":"0001193125-26-206565","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Genesco appoints Ashley Randolph as Chief Accounting Officer effective May 5, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ashley Randolph, 20-year company veteran and former VP/Corporate Controller, named VP and CAO.","Annual base salary of $278,000; target STI of $83,400 (30% of base) and equity target of $139,000 (50% of base).","CEO Mimi Vaughn relinquishes principal accounting officer role but remains interim CFO.","Randolph will oversee accounting operations, financial controls, compliance, and SEC reporting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96217,"accession_number":"0001193125-26-147591","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2026-04-08T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Genesco adopts new Short-Term Incentive Plan for FY2027, replacing EVA Plan","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["STIP effective FY2027; replaces Fourth Amended and Restated EVA Plan.","Awards based on financial, operational, and strategic performance metrics set by Compensation Committee.","Target awards as % of salary or fixed dollar; maximum payout 3x target.","75% of bonus tied to business-unit performance, 25% to individual goals; Committee may reduce payouts.","Clawback and forfeiture provisions included; 120-day employment minimum for eligibility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109911,"accession_number":"0001193125-26-128945","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Genesco CEO Mimi Vaughn adds principal accounting officer role after CFO departure","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Cassandra E. Harris ceased as principal accounting officer effective March 25, 2026, after FY2026 10-K filing.","Mimi E. Vaughn appointed as principal accounting officer on March 26, 2026, until a successor is named.","Vaughn remains President, CEO, Interim CFO and principal financial officer; no extra compensation for new role.","No changes to Vaughn's severance arrangements or equity grants in connection with the appointment.","Transition follows previously announced consulting agreement with Harris for orderly handover."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109910,"accession_number":"0001193125-26-094963","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2026-03-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q4 net sales up 7% to $800M; GAAP EPS $4.43 vs $3.06; comp sales +9% for 6th straight quarter","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Journeys Group Q4 comp sales +12%; overall comps +9% (stores +9%, e-commerce +8%).","GAAP operating income $51.3M (6.4% of sales) vs $46.1M (6.2%) last year; adjusted operating income $55.9M.","Adjusted EPS from continuing ops $3.74 vs $3.26; full-year FY2026 adjusted EPS $1.45 vs $0.94.","Cash $105.4M; inventories +2% YoY; store count 1,236 (net -42 stores for FY2026).","FY2027 guidance: positive comp sales 1-2%; total sales down 1% to flat; adjusted EPS $1.90-$2.30."],"consensus_eps_estimate":null,"consensus_eps_actual":1.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":2436096000.0,"consensus_period":"2026-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109909,"accession_number":"0001193125-26-029634","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2026-01-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Genesco CFO Cassandra Harris resigns effective March 6; CEO Mimi Vaughn named interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Harris resigns to pursue non-retail opportunities; departure not related to any disagreement with the company.","CEO Mimi Vaughn, who served as CFO from 2015 to 2019, will serve as interim CFO effective March 6, 2026, with no additional compensation.","Harris will consult through March 25, 2026, assisting with transition and fiscal year 2026 10-K filing; receives $12,000 for transition services.","Company has initiated a formal search for a permanent CFO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109908,"accession_number":"0001193125-26-018112","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2026-01-21T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Genesco extends credit facility maturity to Jan 2031, adjusts pricing grid","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Fourth Amendment extends maturity of revolving credit facility to January 16, 2031.","Removed credit spread adjustment on Term SOFR, reducing interest rate on domestic borrowings.","Added new pricing grid Level III; Applicable Margin for Term SOFR/Term CORRA loans 1.25%-1.75%.","Financial covenant (fixed charge coverage ratio ≥1.0:1.0) triggered only if Excess Availability < $22.5M or 10% of loan cap.","Conforming change replaces CDOR with Term CORRA for Canadian borrowings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109907,"accession_number":"0001193125-26-009919","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Genesco Q4-to-date comparable sales +9% YoY; raises FY2026 adjusted EPS guidance to at least $1.30","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total comparable sales up 9% for the 8 weeks ended Dec 27, 2025; same-store sales +10%, e-commerce +9%.","Journeys Group comps +12%; Schuh Group +6%; Johnston & Murphy Group +1%.","FY2026 adjusted EPS guidance raised to at least $1.30, a meaningful improvement vs prior outlook.","Holiday performance driven by strong conversion and full-price selling at Journeys; Schuh saw increased discounting.","Management to present at 2026 ICR Conference on Jan 12; webcast available on company website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126493,"accession_number":"0001193125-25-307446","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q3 sales +3% to $616M; adj EPS $0.79; cuts FY adj EPS guidance to ~$0.95","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net sales $616M (+3% YoY); GAAP EPS $0.51 vs ($1.76); Non-GAAP EPS $0.79 vs $0.61.","Comparable sales +3%; Journeys +6%, Schuh -2%, Johnston & Murphy -2%.","FY2026 guidance lowered: adj EPS ~$0.95 (from $1.30-$1.70); sales +~2% (from 3-4%).","Fifth consecutive positive comp quarter; Schuh margin pressure and cautious consumer outlook cited.","Inventory +7% YoY; store count 1,245 (-4% YoY); cash $27M, debt $89.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":1636155000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143236,"accession_number":"0000950170-25-111790","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2025-08-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Genesco Q2 net sales +4% to $546M, beats expectations; raises FY sales outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 GAAP EPS ($1.79) vs ($0.91) last year; Non-GAAP EPS ($1.14) vs ($0.83); operating loss $14.4M.","Comparable sales +4% (stores +5%, e-commerce +1%); Journeys comp +9% for 4th consecutive positive quarter.","Raises FY26 sales guidance: total sales now +3-4% (prior +1-2%), comps +4-5% (prior +2-3%).","Reiterates adjusted EPS guidance $1.30-$1.70; gross margin -100bps to 45.8% due to tariffs and promotions.","Back-to-school off to strong start in Q3 with Journeys comping positive; inventory up 11% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.82,"consensus_revenue_estimate":null,"consensus_revenue_actual":1019938000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161369,"accession_number":"0000950170-25-090855","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2025-06-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Genesco shareholders elect all nine director nominees at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All nine director nominees elected with votes ranging from ~6.5M to ~6.8M for each.","Non-binding advisory vote on executive compensation approved: 6,036,837 for, 624,385 against.","Third Amended and Restated 2020 Equity Incentive Plan approved: 6,130,137 for, 721,879 against.","Ratification of Deloitte & Touche as auditor approved: 7,714,859 for, 109,034 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161368,"accession_number":"0000950170-25-081392","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2025-06-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q1 sales +4% YoY, comparable sales +5%; loss narrows; reiterates FY adj EPS $1.30-$1.70","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $474M (+4% YoY); comparable sales +5% with Journeys +8%, Schuh +1%, J&MG -2%.","GAAP EPS ($2.02) vs ($2.22) last year; Non-GAAP EPS ($2.05) vs ($2.10); operating loss narrowed.","SG&A leveraged 170 bps; gross margin 46.7% adjusted vs 47.6% prior year.","FY2026 guidance: adj EPS $1.30-$1.70 reaffirmed; total sales growth raised to +1-2% (prior flat to +1%).","Repurchased 604,531 shares for $12.6M; ended quarter with 1,256 stores (net -26)."],"consensus_eps_estimate":3.6209,"consensus_eps_actual":-2.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":473973000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161366,"accession_number":"0000950170-25-072567","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K/A","filed_at":"2025-05-15T23:59:59+00:00","items":["4.01"],"status":"ready","headline":"Genesco formally engages Deloitte & Touche as FY2026 independent auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Deloitte completed client acceptance procedures and was formally engaged on May 15, 2025.","Audit committee had previously approved Deloitte for fiscal year ending January 31, 2026.","No consultations occurred between Genesco and Deloitte regarding accounting principles or audit opinions.","No disagreements or reportable events as defined under Item 304 of Regulation S-K were identified."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161367,"accession_number":"0000950170-25-064430","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Genesco dismisses EY as auditor, appoints Deloitte effective April 30, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit Committee dismissed Ernst & Young LLP and appointed Deloitte & Touche LLP as independent auditor, effective April 30, 2025.","EY's reports for Fiscal 2025 and 2024 were unqualified with no adverse opinions or modifications.","No disagreements or reportable events occurred with EY during the past two fiscal years and interim period.","Deloitte appointment subject to client acceptance; no prior consultations with Deloitte on accounting matters.","EY letter agreeing with filing statements is included as Exhibit 16.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179531,"accession_number":"0000950170-25-035140","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2025-03-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q4 comparable sales +10%; adjusted EPS $3.26 beats prior year $2.59","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $746M (+1%); comparable sales +10% led by Journeys +14% and e-commerce +18%.","GAAP Q4 EPS $3.06 vs $1.84; adjusted EPS $3.26 vs $2.59. Operating margin improved to 6.4%.","Full year GAAP loss per share ($1.80) vs ($2.10); adjusted EPS $0.94 vs $0.56.","FY26 guidance: adjusted EPS $1.30-$1.70; total sales flat to +1% vs FY25.","Zero debt; inventory +12% YoY. Achieved $45-50M cost-savings run-rate."],"consensus_eps_estimate":0.8888,"consensus_eps_actual":-1.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":2325062000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179530,"accession_number":"0000950170-25-015844","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2025-02-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Genesco amends exec severance terms: Termination Notice effective during M&A talks, removes auto-retirement cutoff","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["The amendments apply to certain executive officers, excluding CEO Mimi E. Vaughn and Parag D. Desai.","Termination Notice by the Board will not be effective if the Company is in active negotiations for a Change in Control transaction.","The Agreement no longer automatically terminates upon the executive reaching a certain retirement age.","The Compensation Committee approved the amendments on February 6, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179529,"accession_number":"0000950170-25-004174","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2025-01-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Genesco Q4-to-date comparable sales up 10% YoY; reaffirms FY25 EPS guidance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Quarter-to-date comparable sales (8 wks ended Dec 28, 2024) increased 10% vs prior year.","Same-store sales up 6%; e-commerce comparable sales up 20%.","Journeys Group comps up 14%; Schuh up 3%; Johnston & Murphy down 1%.","Company reaffirms FY25 EPS guidance of $0.80-$1.00.","Management cites strong holiday full-price selling and acceleration in store closures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196252,"accession_number":"0000950170-24-135769","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2024-12-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Genesco CFO Thomas George retires; Sandra Harris assumes principal accounting officer role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Thomas A. George retired as Senior VP, Finance and CFO effective December 12, 2024, as part of planned retirement.","Cassandra 'Sandra' Harris, appointed CFO on October 7, 2024, succeeds Mr. George as principal accounting officer.","Ms. Harris previously served as CFO of Artisan Design Group (2023-2024) and Tupperware Brands (2019-2022).","Harris also held senior leadership roles at VF Corporation from 2008 to 2019; she is a CPA and CGMA."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196251,"accession_number":"0000950170-24-133841","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2024-12-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco beats Q3 expectations; raises FY2025 adjusted EPS guidance to $0.80-$1.00","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $596M (+3% YoY); comparable sales +6% driven by Journeys +11% comp.","GAAP EPS ($1.76) includes $26.3M US valuation allowance; Non-GAAP EPS $0.61 vs $0.57 prior year.","Raises FY2025 adjusted EPS guidance to $0.80-$1.00 (from $0.60-$1.00); sales guidance raised to down 1%-flat.","Gross margin 47.8% (-30bps) on product mix; adjusted operating margin 1.7% (down from 1.9% last year).","E-commerce sales 24% of retail (vs 21% last year); store count 1,302; closed 14 stores in quarter."],"consensus_eps_estimate":-1.2591,"consensus_eps_actual":-4.9,"consensus_revenue_estimate":null,"consensus_revenue_actual":1579113000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196250,"accession_number":"0000950170-24-110548","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2024-10-01T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Genesco appoints Sandra Harris as CFO, replacing retiring Thomas George","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sandra Harris named CFO effective Oct 7, 2024, succeeds Thomas George who retires Dec 12.","Harris previously CFO at Artisan Design Group and Tupperware; spent nearly 10 years at VF Corporation.","Compensation includes $600k base salary, 75% target bonus, 150% LTI target, $300k sign-on RSUs.","George remains as principal accounting officer through Dec 12 to ensure orderly transition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212530,"accession_number":"0000950170-24-104228","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2024-09-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q2 net sales $525M, non-GAAP EPS ($0.83) vs ($0.85) YoY; reaffirms FY EPS $0.60-$1.00","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP operating loss $10.3M (2.0% of sales) vs $38.6M loss last year; adjusted operating loss $9.3M.","Comparable sales down 2% overall; Journeys comps improved to -1% from -11% YoY; e-com comps +8%.","Inventory decreased 8% YoY; repurchased $9.3M in stock ($42.8M remaining on authorization).","FY2025 sales outlook narrowed to down 1-2% (excluding 53rd week flat to down 1%); adjusted EPS reaffirmed $0.60-$1.00.","Journeys momentum cited as key driver; store closure plan on track for up to 50 closings in FY2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":982785000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212529,"accession_number":"0000950170-24-079286","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2024-07-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Genesco CFO Thomas George adds principal accounting officer role; CAO Baxter to resign July 31","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Thomas A. George, CFO and SVP-Finance, appointed additional role of principal accounting officer.","Brently G. Baxter to resign as VP and CAO effective July 31, 2024; no disagreement with Company.","Appointment part of finance function restructuring to promote efficiency and reduce costs.","Mr. George will receive no additional compensation for the new role."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231519,"accession_number":"0000950170-24-078431","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2024-06-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Genesco shareholders elect all nine directors and approve all proposals at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All nine director nominees elected, with 'for' votes ranging from ~8.35M to ~8.72M.","Non-binding advisory vote on executive compensation passed with ~8.36M for, ~0.60M against.","Second Amended and Restated 2020 Equity Incentive Plan approved with ~8.29M for, ~0.73M against.","Ratification of Ernst & Young LLP as independent auditor for fiscal year passed with ~9.36M for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231518,"accession_number":"0000950170-24-066921","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2024-05-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q1 operating loss $32.1M; reaffirms FY2025 EPS guidance $0.60-$1.00","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $458M (-5% YoY); comparable sales -5%; e-commerce +3% to 23% of retail sales.","GAAP EPS loss ($2.22); Non-GAAP EPS loss ($2.10); adjusted operating loss $30.0M.","Inventory down 17% YoY; closed 21 stores during quarter; 1,321 total stores.","Journeys comp sales -5%; Johnston & Murphy -3%; Schuh -7%; Genesco Brands -25%.","FY2025 outlook reaffirmed: total sales -2% to -3%, adj. EPS $0.60-$1.00."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":457597000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231516,"accession_number":"0000950170-24-060416","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K/A","filed_at":"2024-05-15T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Genesco increases share repurchase authorization by $50M to $250M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Existing $200M authorization: $189.5M used on 3.9M shares since Sep 2019, leaving $10.5M.","Board approved $50M increase to repurchase authorization, bringing total to $250M.","Current quarter: ~676k shares repurchased for $14.5M at avg $21.41 per share.","Since Dec 2018: 9.2M shares repurchased for $415M, representing over 46% of outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.15,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231517,"accession_number":"0000950170-24-052957","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2024-05-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Genesco adopts Executive Severance Plan covering key officers with 12-24 month severance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan covers key management, including named executive officers, upon involuntary termination or good reason resignation.","Severance pay equals 12 months of base salary for non-CEO participants, 24 months for CEO.","Participants receive COBRA premium subsidy for same period as severance pay.","Severance conditioned on signing a release agreement and complying with restrictive covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249881,"accession_number":"0000950170-24-028367","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2024-03-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q4 non-GAAP EPS $2.59; FY24 GAAP loss; FY25 adj EPS guidance $0.60-$1.00","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $739M (+2% vs 13-wk prior year); comps down 4%; e-commerce 27% of retail.","GAAP EPS from cont ops $1.84 (Q4) vs $3.23; FY24 GAAP loss $23.6M, or ($2.10) per share.","Non-GAAP EPS from cont ops $2.59 (Q4) vs $3.06; FY24 non-GAAP EPS $0.56 vs $5.59.","FY25 guidance: total sales down 2%-3%; adj diluted EPS $0.60-$1.00; tax rate 26%.","Closed 94 Journeys stores in FY24; targeting 50 more closures; cost savings run rate $45-$50M."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.5,"consensus_revenue_estimate":null,"consensus_revenue_actual":2324624000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249880,"accession_number":"0000950170-24-002712","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2024-01-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Genesco cuts FY2024 adjusted EPS guidance to $0.65-$0.85 from $1.50-$2.00","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4-to-date comparable sales decreased 4% YoY; store sales -6%, direct sales +3%.","Journeys comparable sales -6%, Schuh -5%, Johnston & Murphy +11%.","Now expects FY2024 adjusted EPS near midpoint of $0.65-$0.85 range.","CEO cites choppy holiday trends and weaker boot sales at Journeys."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":267358,"accession_number":"0000950170-23-067148","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2023-12-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q3 sales down 4% to $579M, adj EPS $0.57; lowers FY outlook to $1.50-$2.00","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $579M, down 4% YoY; comparable sales -4% (stores -7%, direct +8%).","GAAP EPS from cont ops $0.60 vs $1.66; adjusted EPS $0.57 vs $1.65.","Operating income $10.9M (1.9% margin) vs $26.1M (4.3%) last year.","Gross margin 48.1%, down 60 bps due to increased promotions at Journeys.","FY2024 adjusted EPS guidance lowered to $1.50-$2.00; expects sales down 1-2%."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.88,"consensus_revenue_estimate":null,"consensus_revenue_actual":1585674000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":267357,"accession_number":"0000950170-23-066241","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2023-11-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Genesco names Andy Gray President of Journeys Group, effective Jan 3, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Andy Gray, former Foot Locker global president, appointed President of Journeys Group, effective Jan 3, 2024.","Gray succeeds Mario Gallione, whose planned retirement was announced in August 2023.","Gray to receive annual base salary of $635,000, target incentive of 75% of salary, and LTI award of 150% of compensation.","Gray will get relocation assistance up to $100k, $25k relocation bonus, and $25k quarterly travel stipend until July 2025.","Gray has no family relationships or reportable transactions with the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":284612,"accession_number":"0000950170-23-045610","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2023-08-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco posts Q2 GAAP loss per share of $2.79; non-GAAP loss $0.85; sales down 2%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $523M, down 2% YoY; GAAP loss from cont. ops $31.6M ($2.79 loss per share).","Non-GAAP loss per share $0.85 vs. income $0.59 last year; gross margin +20bps to 47.7%.","Recorded $28.5M pretax goodwill impairment in Genesco Brands Group due to licensor dispute.","Journeys comps down 11%, Schuh +17%, J&Murphy +12%; e-commerce 21% of retail sales.","Repurchased $22.9M in shares (1.0M shares avg $22.71); FY24 EPS guidance reaffirmed $2.00-$2.50."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":1006359000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":284611,"accession_number":"0000950170-23-045544","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2023-08-31T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Genesco announces Journeys Group President Mario Gallione to retire Feb 2024; search for successor underway","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mario Gallione to retire effective February 3, 2024, after 44 years at Genesco.","Gallione will serve as President Emeritus through Feb 3, 2024, then consultant until June 28, 2024.","Mike Sypert, 34-year veteran, named Journeys COO to lead transition and assume day-to-day responsibilities.","Executive search firm Egon Zehnder engaged to find Gallione's successor, considering internal and external candidates.","Gallione to receive current salary of $42,500/month through Oct 28, then $12,500/month until Feb 3, plus consulting fees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304331,"accession_number":"0000950170-23-029855","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2023-06-26T23:59:59+00:00","items":["5.02","5.07","8.01","9.01"],"status":"ready","headline":"Genesco increases share repurchase authorization by $50M to $60.5M total; extends CFO through March 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized $50M increase to its $200M buyback program; total remaining authorization now $60.5M.","Repurchased 676k shares in current quarter at avg $21.41; since Dec 2018 repurchased 9.2M shares (>46% of shares outstanding).","CFO Thomas George's employment extended through March 2025; salary increased to $530K in FY2025, plus restricted stock awards.","Shareholders elected all 9 directors and approved non-binding Say-on-Pay and the amended 2020 Equity Incentive Plan.","Annual meeting ratified Ernst & Young as independent auditor for the fiscal year."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304330,"accession_number":"0000950170-23-024059","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2023-05-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q1 loss per share $1.60; guides FY24 adjusted EPS $2.00-$2.50","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $483M (-7% YoY); GAAP loss from continuing ops $18.9M ($1.60 loss per share).","Non-GAAP EPS loss $1.59 vs profit $0.44 prior year; adjusted operating margin -4.7%.","Journeys comps down 14%; Schuh and Johnston & Murphy comps up 13% and 18%.","Revises FY24 outlook: sales down 4-5% (ex-53rd week down 5-6%); adjusted EPS $2.00-$2.50.","Plans to close >100 Journeys stores in FY24 (was ~60) and cut up to $40M in costs."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.6,"consensus_revenue_estimate":null,"consensus_revenue_actual":483332000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323958,"accession_number":"0000950170-23-011377","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2023-03-31T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Genesco amends EVA incentive plan, caps bonuses at 3x target, phases out bonus banks","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Compensation committee amended EVA plan to cap bonuses at 3x target and eliminate future bonus bank contributions starting FY2024.","Existing positive bonus banks (Schuh Group only) to be paid in equal annual installments over next three fiscal years.","Negative bonus banks subject to payback rules; no bonus banks remain after FY2026.","Board Chair, President and CEO Mimi Vaughn added as participant; performance goals to be set by compensation committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323957,"accession_number":"0000950170-23-006835","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2023-03-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q4 EPS $3.06 vs $3.48 YoY; FY23 non-GAAP EPS $5.59; guides FY24 $5.10-$5.90","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $725M flat YoY; GAAP EPS $3.23 vs $4.41; non-GAAP EPS $3.06 vs $3.48.","Full year net sales $2.38B down 2%; GAAP EPS $5.69 vs $7.92; non-GAAP EPS $5.59 vs $7.62.","Q4 comparable sales up 5% with e-commerce up 15%; e-commerce represented 25% of retail sales.","FY2024 guidance: adjusted EPS $5.10-$5.90, sales flat to up 2% (ex-53rd week down 1% to up 1%).","Inventory increased 65% YoY; share repurchases $72.7M in FY23 with $34.1M authorization remaining."],"consensus_eps_estimate":null,"consensus_eps_actual":5.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":2384888000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323956,"accession_number":"0000950170-23-000423","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2023-01-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Genesco Q4-to-date comp sales up 3%; guides FY adjusted EPS to low end of $5.50-$5.90","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4-to-date comparable sales (stores + direct) +3% YoY; same-store sales -2%, direct +22%.","Journeys overall sales -3%; Schuh +6%; Johnston & Murphy +11%; Licensed Brands -39%.","Fiscal 2023 adjusted EPS now expected at low end of $5.50-$5.90 range (prior midpoint view).","Lower guidance driven by higher shipping/warehouse expense and December U.S. store deleverage.","Total overall sales -2% YoY for the quarter-to-date period ended Dec 24, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341932,"accession_number":"0000950170-22-025971","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2022-12-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q3 adj. EPS falls to $1.65 from $2.36; lowers FY23 guidance to $5.50-$5.90","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $604M, +1% YoY; comps +3%; e-commerce 18% of retail sales.","GAAP EPS from cont ops $1.66; non-GAAP EPS $1.65 vs $2.36 last year and $1.33 pre-pandemic.","Gross margin 48.7% (-50 bps YoY); adj. operating margin 4.4% vs 7.5% last year.","Repurchased $20.8M stock in Q3; $34.1M remaining on authorization.","FY23 adj. EPS guidance cut to $5.50-$5.90 (mid $5.70) from $6.25-$7.00; sales -1% to -2%."],"consensus_eps_estimate":null,"consensus_eps_actual":2.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":1659868000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341931,"accession_number":"0000950170-22-025573","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2022-11-22T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Genesco appoints Best Buy CFO and Sephora EVP to board; two directors retire","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Matt Bilunas (Best Buy CFO) and Carolyn Bojanowski (Sephora EVP) join board effective Jan 29, 2023.","Matthew C. Diamond and Kevin P. McDermott to retire and not stand for reelection at 2023 Annual Meeting.","Board temporarily expanded to 11 directors; will revert to 9 after annual meeting.","Both new directors are independent under NYSE; Bilunas on audit, Bojanowski on nominating/governance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341930,"accession_number":"0000950170-22-020877","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2022-11-01T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Genesco board approves amended bylaws to align with SEC Rule 14a-19 on director nominations","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Amended bylaws require shareholders nominating directors to fully comply with Rule 14a-19, including proxy solicitation.","New rules cap the number of director nominees a shareholder can propose at the number of seats up for election.","Company may disregard proxies or votes if the shareholder fails to comply with Rule 14a-19 notice and filing requirements.","Shareholders soliciting proxies from others must use a proxy card color other than white.","Amendments effective October 27, 2022; redline of changes filed as Exhibit 3.2."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358769,"accession_number":"0000950170-22-018002","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2022-09-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q2 adj EPS $0.59 vs $1.05 last year; cuts FY23 EPS guidance to $6.25-$7.00","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $535M, down 4% YoY but up 10% vs pre-pandemic Q2FY20; retail comps -2%.","GAAP EPS from cont ops $0.59; adjusted EPS $0.59 (vs $1.05 last year).","Full-year adj EPS guidance cut to $6.25-$7.00 (prior mid-point $7.00-$7.75), citing inflation headwinds.","Repurchased $45.4M of stock in Q2; $54.9M remaining on authorization.","Inventory +55% YoY; Journeys comps -8%, Johnston & Murphy +17%, Schuh +9% on constant currency."],"consensus_eps_estimate":null,"consensus_eps_actual":0.95,"consensus_revenue_estimate":null,"consensus_revenue_actual":1056080000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":377519,"accession_number":"0000950170-22-012117","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2022-06-24T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Genesco shareholders re-elect all nine directors, approve majority voting standard and executive compensation","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All nine director nominees elected; votes ranged from 10.7M to 11.7M for, with broker non-votes of ~447k.","Advisory vote on executive compensation approved: 8.80M for, 3.00M against, 8.5k abstain, 447k broker non-votes.","Shareholders approved articles of amendment to implement majority voting for directors: 11.76M for, 7.8k against, 33.8k abstain.","Ratification of Ernst & Young as auditor approved: 11.91M for, 335k against, 3.7k abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":377518,"accession_number":"0000950170-22-010705","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2022-05-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q1 adj EPS $0.44 beats expectations; reaffirms FY23 adj EPS $7.00-$7.75","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $521M, down 3% YoY but up 5% vs pre-pandemic Q1FY20 with 90 fewer stores.","GAAP EPS $0.37; adjusted EPS $0.44, exceeding profitability expectations.","E-commerce sales down 29% YoY but up 74% vs pre-pandemic; represented 19% of retail sales.","Reaffirms FY23 adjusted EPS guidance $7.00-$7.75; expects near midpoint.","Repurchased 102,895 shares at avg $63.17; $100.3M remaining on authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":0.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":520748000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":395906,"accession_number":"0000950170-22-003300","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2022-03-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Genesco Q4 net sales $728M (+14% YoY); adj EPS $3.48 vs $2.76; FY adj EPS $7.62 record; FY23 guidance $7.00-$7.75","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $728M (+14% YoY, +7% vs pre-pandemic); gross margin 48.9% (+310bps vs last year).","Adjusted EPS from cont ops $3.48 (Q4) vs $2.76 last year; FY adj EPS $7.62 record vs $(1.18) loss in FY21.","FY22 full-year net sales $2.4B (+36% YoY); operating cash flow $240M; repurchased $82.8M in stock (9% of shares outstanding).","Fiscal 2023 guidance: adj EPS $7.00-$7.75 (near midpoint); sales growth 2-4%; tax rate 27-28%."],"consensus_eps_estimate":null,"consensus_eps_actual":7.92,"consensus_revenue_estimate":null,"consensus_revenue_actual":2422084000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":395905,"accession_number":"0000950170-22-000800","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2022-02-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Genesco adds $100M to share repurchase program; total authorization now $101M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved $100M increase to existing repurchase program; prior remaining authorization was $1M.","In FY2022, repurchased 1.36M shares for $82.8M at average price of $60.88 per share.","Since Dec 2018, repurchased ~7.0M shares ($324M, avg $46.34), representing over 34% of shares outstanding.","Purchases may be made in open market or private transactions; no obligation to repurchase any amount."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":395904,"accession_number":"0000950170-22-000748","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2022-02-03T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Genesco amends credit agreement: maturity extended to 2027, margin reduced 1%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Extended maturity to Jan 28, 2027; removed $17.5M term loan.","Borrowing base expanded: in-transit inventory (≤15% of base, 75% advance rate) and real estate (up to 25%, 60% advance rate).","Seasonal inventory advance rate increased to 92.5% for four months; intellectual property excluded from collateral.","No financial covenants unless Excess Availability < $22.5M or 10% of loan cap; then fixed charge coverage ratio ≥1.0:1.0.","Applicable Margin on revolver reduced by 1.00%; replaced LIBOR with SOFR."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":395903,"accession_number":"0001564590-22-000768","cik":18498,"company_name":"GENESCO INC","ticker":"GCO","form_type":"8-K","filed_at":"2022-01-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Genesco QTD total sales up 18% YoY; reaffirms FY22 EPS guidance at $6.40-$6.90, expecting above midpoint","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total overall sales for the 8 weeks ended Dec 25, 2021 increased 18% vs FY21 and 9% vs FY20.","Journeys +8%, Schuh +28%, Johnston & Murphy +53%, Licensed Brands +104% vs FY21.","CEO cites strong full-price holiday selling despite supply chain challenges; January trend moderated due to lean inventory.","Reaffirms FY22 EPS guidance of $6.40-$6.90, with expectation now above midpoint; adjusted EPS above midpoint expected.","Direct sales fell 10% vs FY21 but rose 33% vs FY20; store sales up 18% vs FY21, down 2% vs FY20."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":403708777.15248793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-01-10T23:59:59+00:00|395903"}